000			02060 a2200577 4500
005			20250515014910.0
264		0	_c20061109
008			200611s 0 0 eng d
022			_a0903-1936
024	7		_a10.1183/09031936.06.00015605 _2doi
040			_aNLM _beng _cNLM
100	1		_aHuber, R M
245	0	0	_aEfficacy of a toxicity-adjusted topotecan therapy in recurrent small cell lung cancer. _h[electronic resource]
260			_bThe European respiratory journal _cJun 2006
300			_a1183-9 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAntineoplastic Agents _xadministration & dosage
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aCarcinoma, Small Cell _xdrug therapy
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Administration Schedule
650	0	4	_aDrug Resistance, Neoplasm
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aLeukocyte Count
650	0	4	_aLung Neoplasms _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Recurrence, Local _xdrug therapy
650	0	4	_aNeoplasm Staging
650	0	4	_aNeutropenia _xchemically induced
650	0	4	_aNeutrophils _xdrug effects
650	0	4	_aOrganoplatinum Compounds _xtherapeutic use
650	0	4	_aPlatelet Count
650	0	4	_aRetreatment
650	0	4	_aSurvival Rate
650	0	4	_aTopotecan _xadministration & dosage
650	0	4	_aTreatment Outcome
700	1		_aReck, M
700	1		_aGosse, H
700	1		_avon Pawel, J
700	1		_aMezger, J
700	1		_aSaal, J G
700	1		_aKleinschmidt, R
700	1		_aSteppert, C
700	1		_aSteppling, H
773	0		_tThe European respiratory journal _gvol. 27 _gno. 6 _gp. 1183-9
856	4	0	_uhttps://doi.org/10.1183/09031936.06.00015605 _zAvailable from publisher's website
999			_c16093179 _d16093179